(19)
(11) EP 4 798 242 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883187.7

(22) Date of filing: 22.10.2024
(51) International Patent Classification (IPC): 
A61K 47/14(2017.01)
A61K 47/20(2006.01)
 A61K 47/10(2017.01)
A61K 47/36(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/2013; A61K 9/5015
(86) International application number:
PCT/US2024/052403
(87) International publication number:
WO 2025/090498 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 23.10.2023 US 202363592229 P

(71) Applicant: ISP Investments LLC
Wilmington, Delaware 19805 (US)

(72) Inventors:
  • DURIG, Thomas
    Chadds Ford, Pennsylvania 19317 (US)
  • KARAN, Kapish
    Wilmington, DE 19807 (US)

(74) Representative: Kutzenberger Wolff & Partner 
Waidmarkt 11
50676 Köln
50676 Köln (DE)

   


(54) ENCAPSULATED MEDIUM CHAIN FATTY ACID SALTS AND ORAL SOLID DOSAGE FORMS DERIVED THEREFROM